We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Psychiatric disorders are complex and multifaceted conditions that profoundly impact various aspects of an individual’s life. Although the neurobiology of these disorders is not fully understood, extensive research suggests intricate interactions between genetic factors, changes in brain structure, disruptions in neurotransmitter pathways, as well as environmental influence.
In the case of psychotic disorders, such as schizophrenia, strong genetic components have been identified as a key feature in the development of psychosis. Moreover, alterations in dopamine function and structural brain changes that result in volume loss seem to be pervasive in people affected by these disorders. Meanwhile, mood disorders, including major depressive disorder and bipolar disorder, are characterized by disruptions in neurotransmitter systems responsible for mood regulation, such as serotonin, norepinephrine, and dopamine. Anxiety and personality disorders also exhibit neurotransmitter dysfunction and neuroanatomical changes, in addition to showing a genetic overlap with mood and psychotic disorders.
Understanding the underlying mechanisms in the pathophysiology of these conditions is of paramount importance and involves integrating findings from various research areas, including at the molecular and cellular levels. This brief overview aims to highlight some of the important developments in our current understanding of psychiatric disorders. Future research should aim to incorporate a comprehensive approach to further unravel the complexity of these disorders and pave the way for targeted therapeutic strategies and effective treatments to improve the lives of individuals afflicted by them.
Schizophrenia spectrum disorders are brain diseases that are developmental dementias (dementia praecox). Their pathology begins in utero with psychosis most commonly becoming evident in adolescence and early adulthood. It is estimated they afflict the U.S. population at a prevalence rate of approximately 0.8%. Genetic studies indicate that these brain diseases are about 80% determined by genes and about 20% determined by environmental risk factors. Inheritance is polygenic with some 270 gene loci having been identified as contributing to the risk for schizophrenia. Interestingly, many of the identified gene loci and gene polymorphisms are involved in brain formation and maturation. The identified genetic and epigenetic risks give rise to a brain in which neuroblasts migrate abnormally, assume abnormal locations and orientations, and are vulnerable to excessive neuronal and synaptic loss, resulting in overt psychotic illness. The illness trajectory of schizophrenia then is one of loss of brain mass related to the number of active psychotic exacerbations and the duration of untreated illness. In this context, molecules such as dopamine, glutamate, and serotonin play critical roles with respect to positive, negative, and cognitive domains of illness. Acutely, antipsychotics ameliorate active psychotic illness, especially positive signs and symptoms. The long-term effects of antipsychotic medications have been debated; however, the bulk of imaging data suggest that antipsychotics slow but do not reverse the illness trajectory of schizophrenia. Long-acting injectable antipsychotics (LAI) appear superior in this regard. Clozapine remains the “gold standard” in managing treatment-resistant schizophrenia.
The environment represents a central research object in the Developmental Origins of Health and Disease (DOHaD) and related fields such as epigenetics. This chapter discusses how DOHaD researchers operationalise and measure environments in and through their research practices to produce knowledge on how environmental experiences relate to health outcomes over the lifecourse. While DOHaD researchers discursively acknowledge the complexity of lived environments, we identify some of the current challenges to put this complexity into research practice, often resulting in reductionist accounts of the dynamic nature of human experiences. By proposing the term ’doing environments,’ we emphasise how practices to enact environments for scientific inquiry are products of decisions and negotiation processes that need careful consideration on what social and political consequences these ’doings’ might have and for whom. To that end, we aim to lay the ground for interdisciplinary conversations to engage in critical reflections about the social and political dimensions of doing environments in DOHaD research.
This chapter explores the relationship between climate distress – particularly fear and sadness about climate change – and clinical-level psychiatric symptoms in children and young people, focusing on pediatric anxiety and depression. In response to societal tendencies to under- or overplay the mental health risks of climate emotional impacts, it describes the spectrum of healthy and unhealthy pediatric anxiety and depression, the role that chronic stress and direct climate impacts play on child and adolescent brain development and clinical syndromes, and the ways that responding emotionally to climate change can influence youth identity development and emotional strength. The chapter provides a template for how to assess young people’s climate emotions clinically, offering several detailed case descriptions to illustrate how stress, psychopathology, psychological and brain development, and climate emotions can weave together to influence the sum of a young person’s presentation. As parents’ and other adults’ responses play a key role in whether these emotions evolve to a clinical level, it also suggests some best practices for interacting with climate-distressed youth to minimize poor clinical outcomes.
Edited by
Allan Young, Institute of Psychiatry, King's College London,Marsal Sanches, Baylor College of Medicine, Texas,Jair C. Soares, McGovern Medical School, The University of Texas,Mario Juruena, King's College London
There is no consensus for the concept of treatment-resistant depression (TRD). Although some authors argue considering TRD a depression subtype is not supported by evidence, its impact on the individual and society is clear. This chapter discusses the concept of TRD, presents evidence about its neurobiology, pharmacological interventions, and describes drugs currently under investigation. Among the pharmacological strategies to manage TRD, guidelines include increasing the antidepressant dose, switching to another new antidepressant, combining two or more antidepressants, and augmentation of the current medication. Several new components have been investigated for TRD targeting, for instance, the glutamatergic system, inflammatory system, the opioid system, the cholinergic system, dopaminergic system, and neurotrophin signaling. Finally, machine-learning techniques using clinical and neurobiological data provide promising information about treatment outcomes prediction that could change the current approach to a more personalized one.
This commentary discusses opportunities for advancing the field of developmental psychopathology through the integration of data science and neuroscience approaches. We first review elements of our research program investigating how early life adversity shapes neurodevelopment and may convey risk for psychopathology. We then illustrate three ways that data science techniques (e.g., machine learning) can support developmental psychopathology research, such as by distinguishing between common and diverse developmental outcomes after stress exposure. Finally, we discuss logistical and conceptual refinements that may aid the field moving forward. Throughout the piece, we underscore the profound impact of Dr Dante Cicchetti, reflecting on how his work influenced our own, and gave rise to the field of developmental psychopathology.
Edited by
David Kingdon, University of Southampton,Paul Rowlands, Derbyshire Healthcare NHS foundation Trust,George Stein, Emeritus of the Princess Royal University Hospital
Eating disorders are complex and serious illnesses that can result in physical and psychiatric comorbidities, medical emergencies and progressive health consequences. Although general psychiatrists may be called upon to assist in emergencies or differential diagnoses, training in this area has been limited. The author attempts to fill the gap by providing a summary of the most recent advances in the field of eating disorders in this chapter to help orient trainees and general psychiatrists. This chapter provides an overview of the most recent changes to the DSM-5 and ICD-11 diagnostic categories for eating disorders, as well as their epidemiology, aetiology and treatment, including the management of complications and life-threatening medical emergencies.
The chapter summarises recent advances in the genetic and neurobiological understanding of eating disorders, as well as emerging new research. These scientific advances have the potential to contribute to the development of new, more-effective eating disorder treatments in the future.
This paper critically analyses the hypothesis of the aetiological link between EDCs and trans identities from a scientific point of view, evincing its lack of evidence. It also problematizes the hypothesis by drawing from gender studies scholars who have denounced the transsex panic underlying the scientific literature on the effects of EDC on non-human animals, as well as from philosophical, biological, STG studies’, and neuroscientific elaborations that address sex-gender identities. It finds that the hypothesis that causally links prenatal exposure to EDCs and trans identities, which fuses biological determinism with a toxic and perturbing element, not only obscures the dynamic processual and relational character of trans identities, but also offers a pathologising understanding of them.
Bringing together an international team of scholars, this pioneering book presents the first truly systematic, cross-linguistic study of variation in literacy development. It draws on a wide range of cross-cultural research to shed light on the key factors that predict global variation in children's acquisition of reading and writing skills, covering regions as diverse as North and South America, Asia, Australia, Europe and Africa. The first part of the volume deals with comprehensive reviews related to the variation of literacy in different regions of the globe as a function of socio-political, sociocultural, and language and writing system factors. The second part of the volume deals with comprehensive reviews related to the variation of literacy in different world regions. Offering a pioneering new framework for global literacy development, this groundbreaking volume will remain a landmark in the fields of literacy development and literacy teaching and learning for years to come.
Organoids and specifically human cerebral organoids (HCOs) are one of the most relevant novelties in the field of biomedical research. Grown either from embryonic or induced pluripotent stem cells, HCOs can be used as in vitro three-dimensional models, mimicking the developmental process and organization of the developing human brain. Based on that, and despite their current limitations, it cannot be assumed that they will never at any stage of development manifest some rudimentary form of consciousness. In the absence of behavioral indicators of consciousness, the theoretical neurobiology of consciousness being applied to unresponsive brain-injured patients can be considered with respect to HCOs. In clinical neurology, it is difficult to discern a capacity for consciousness in unresponsive brain-injured patients who provide no behavioral indicators of consciousness. In such scenarios, a validated neurobiological theory of consciousness, which tells us what the neural mechanisms of consciousness are, could be used to identify a capacity for consciousness. Like the unresponsive patients that provide a diagnostic difficulty for neurologists, HCOs provide no behavioral indicators of consciousness. Therefore, this article discusses how three prominent neurobiological theories of consciousness apply to human cerebral organoids. From the perspective of the Temporal Circuit Hypothesis, the Global Neuronal Workspace Theory, and the Integrated Information Theory, we discuss what neuronal structures and functions might indicate that cerebral organoids have a neurobiological capacity to be conscious.
The Roman high-avoidance (RHA) and low-avoidance (RLA) rat lines/strains were established in Rome through bidirectional selection of Wistar rats for rapid (RHA) or extremely poor (RLA) acquisition of a two-way active avoidance task. Relative to RHAs, RLA rats exhibit enhanced threat sensitivity, anxiety, fear and vulnerability to stress, a passive coping style and increased sensitivity to frustration. Thus, RLA rats’ phenotypic profile falls well within the “internalizing” behavior spectrum. Compared with RLAs and other rat strains/stocks, RHAs present increased impulsivity and reward sensitivity, deficits in social behavior and attentional/cognitive processes, novelty-induced hyper-locomotion and vulnerability to psychostimulant sensitization and drug addiction. Thus, RHA rats’ phenotypes are consistent with a “disinhibiting externalizing” profile. Many neurobiological/molecular traits differentiate both rat lines/strains. For example, relative to RLA rats, RHAs exhibit decreased function of the prefrontal cortex (PFC), hippocampus and amygdala, increased functional tone of the mesolimbic dopamine system, a deficit of central metabotropic glutamate-2 (mGlu2) receptors, increased density of serotonin 5-HT2A receptors in the PFC, impairment of GABAergic transmission in the PFC, alterations of several synaptic markers and increased density of pyramidal immature dendrític spines in the PFC. These characteristics suggest an immature brain of RHA rats and are reminiscent of schizophrenia features like hypofrontality and disruption of the excitation/inhibition cortical balance. We review evidence supporting RLA rats as a valid model of anxiety/fear, stress and frustration vulnerability, whereas RHA rats represent a promising translational model of neurodevelopmental alterations related to impulsivity, schizophrenia-relevant features and comorbidity with drug addiction vulnerability.
Trauma exposure is prevalent globally and is a defining event for the development of posttraumatic stress disorder (PTSD), characterised by intrusive thoughts, avoidance behaviours, hypervigilance and negative alterations in cognition and mood. Exposure to trauma elicits a range of physiological responses which can interact with environmental factors to confer relative risk or resilience for PTSD. This systematic review summarises the findings of longitudinal studies examining biological correlates predictive of PTSD symptomology. Databases (Pubmed, Scopus and Web of Science) were systematically searched using relevant keywords for studies published between 1 January 2021 and 31 December 2022. English language studies were included if they were original research manuscripts or meta-analyses of cohort investigations that assessed longitudinal relationships between one or more molecular-level measures and either PTSD status or symptoms. Eighteen of the 1,042 records identified were included. Studies primarily included military veterans/personnel, individuals admitted to hospitals after acute traumatic injury, and women exposed to interpersonal violence or rape. Genomic, inflammation and endocrine measures were the most commonly assessed molecular markers and highlighted processes related to inflammation, stress responding, and learning and memory. Quality assessments were done using the Systematic Appraisal of Quality in Observational Research, and the majority of studies were rated as being of high quality, with the remainder of moderate quality. Studies were predominantly conducted in upper-income countries. Those performed in low- and middle-income countries were not broadly representative in terms of demographic, trauma type and geographic profiles, with three out of the four studies conducted assessing only female participants, rape exposure and South Africa, respectively. They also did not generate multimodal data or use machine learning or multilevel modelling, potentially reflecting greater resource limitations in LMICs. Research examining molecular contributions to PTSD does not adequately reflect the global burden of the disorder.
Adverse childhood experiences (ACEs), including family dysfunction as well as abuse and neglect, have enduring effects on development. Research across diverse populations documents that ACEs are prevalent and cumulative, influencing children’s developing mental, emotional, and physical systems that affect long-term physical and mental health, social relationships, and parenting attitudes and behaviors. Protective and compensatory experiences (PACEs), including nurturing relationships and stable, supportive environments, can mitigate the effects of ACEs, disrupting the intergenerational transmission of adversity. In this chapter, we summarize the effects of ACEs on neurobiological, cognitive, social, and emotional development. Next, we discuss the effects of cumulative protective experiences and the introduce the concept of Balanced Parenting to promote resilience in the face of adversity. We include examples of how parents and other caregivers can effectively parent children with a history of ACEs at different developmental stages, and conclude with a discussion of new directions for research and practice.
We argue that the representational primes of the human phonological faculty, the so-called distinctive features, are innate and substance-free. Our arguments for the innateness of features are built on traditional and novel logical arguments, experimental evidence accumulating over recent decades, and somewhat detailed proposals about their neurobiological reality. As symbols in the brain, features are substance-free, that is, they are devoid of articulatory and acoustic content, or even any direct reference to such phenomena. This is consistent with our substance-free conception of phonological computation, an approach that eschews functionalist notions like markedness, ease of articulation, and so on. We also outline a neural model of the phonetics-phonology interface called Cognitive Phonetics, which transduces innate features to speech articulation and from speech acoustics. These extra-grammatical transduction procedures are also part of the human biological endowment, which leaves no room for language-specific phonetics in our theory of the externalization of language. We show how Cognitive Phonetics can account for traditionally recognized intersegmental coarticulation, as well as the previously unexplored intrasegmental coarticulation, strongly suggesting that the basic units of speech production are transduced features.
Although difficult to define, the concept of evil is widely used and implicitly influences psychiatric judgements and diagnosis. Most definitions of evil rely on classical philosophical concepts, but it remains controversial if evil is a concept by itself or rather a dysfunction on the ability to experience goodness. Also, it is unclear if there is a neurobiological basis for evil or if it is entirely dependent on socio-cultural beliefs.
Objectives
In this work, we intend to systematize evidence on the philosophical definitions and neurobiological correlates of evil, and reflect on its implications in clinical psychiatry.
Methods
Literature review.
Results
The concept of evil has been a theme of debate since the ancient Greek, where Plato argued that evil was a result of ignorance and Aristoteles saw morality as a guide for education and politics. Nietzsche claimed that evil was a dangerous concept that was created by the church, while Hannah Arendt underlined the banality of evil by highlighting “thoughtlessness” that frequently justify evil acts. From a neurobiological perspective, studies assessing individuals with neuro-psychiatric conditions associated with evil-related behavioral abnormalities have been suggesting a potential role of frontal and limbic structures, as well as of the serotonergic system. However, several of these studies assessed presumed correlates of evil, such as antisocial personality disorder or impulsive-aggressive behavior.
Conclusions
Despite the polemic frontier between neurosciences and morality, a conceptual insight over the definition of evil is vital to guide comprehensiveness and clinical approach when dealing with deviant evil-like behaviors.
This chapter is intended to provide a neurobiologically based framework to understand the behavioral problems seen in PWS. These abnormalities are as a direct result of the loss of function of chromosome 15q11-13. The main brain abnormalities in PWS arise from a dysfunction of areas of higher functioning such as the hypothalamus, insula, orbitofrontal, and anterior cingulate cortices. Additionally, there is abnormal functioning of the serotonin, dopamine, and norepinephrine systems. These dysfunctions collectively lead to the failure of the response monitoring or model-based learning function of the brain. Inadequate or impaired functioning of the response monitoring system in patients with PWS leads to multiple issues including impulsivity and response perseveration. Finally, in place of utilizing the response monitoring system, patients with PWS resort to habit-based learning, which leads to inflexibility. Reminding ourselves of the complex neurobiology that drives our patients and loved ones with PWS might lead to better tolerance for their maladaptive behaviors and more useful management strategies.
This chapter introduces a rationale for a YA Temperament Based Therapy with Support version of treatment. In YATBT-S, parents are primary “Supports,” or the “S” in TBT-S. This chapter addresses concepts unique to young adult development, including a model for parental involvement specifically tailored for the YA life stage. It addresses why parents need to be included in treatment for YA with AN. Components of YA developmental stages and forms of parental assistance are outlined to establish a collaborative, interdependent treatment model.
For those with anorexia nervosa, it is (1) not a “natural” or dominant brain response to eating like those without AN. (2)It is difficult to trust what and when to eat. (3) It is not typical to experience pleasure in eating a variety of foods. (4) Eating is anxiety provoking. Not eating appears to reduce anxiety. Individuals with AN tend to experience reduced sensitivity to reward and increased sensitivity to punishment. Altered sensitivity to reward and punishment is observed in those with AN, for both food and general rewards/losses and thus suggests a broader deficit in reward processing. Hunger does not increase reward sensitivity in AN, suggesting a deficit in translating physiological signals to motivated behavior, and explaining why individuals with AN can restrict food despite starvation. Altered reward processing may be why we see low motivation for recovery and anhedonia. Decreased brain response to reward in the cognitive circuitry in AN is associated with elevated anxiety, suggesting a brain basis for coding food as risky.
Studies show that eating disorders tend to run in families. This suggests genes contribute to eating disorders. Genes cause traits. Several studies show people with eating disorders share traits that existed before the disorder, and they appear to contribute toward maintaining the disorder. For example perfectionism, obsessionality, high achievement orientation, and anxiety are common AN traits. Brain imaging studies show differences in the parts of the brain involved in eating in individuals with eating disorders compared with those who do not have eating disorders. Together, research shows there are strong genetic and neurobiological causes of eating disorders.